Not applicableNot Yet RecruitingNCT07443592What this trial is testingTreatment for Ph-negative ALL for Adults up to 65 YearsWho this might be right forAcute Lymphoblastic Leukemia PETHEMA Foundation 330
Early research (Phase 1)Study completedNCT00351975What this trial is testingBelinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other DiseasesWho this might be right forAccelerated Phase of DiseaseAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+17 more National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)Looking for participantsNCT05660473What this trial is testingPediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic LeukemiaWho this might be right forPrecursor Cell Lymphoblastic Leukemia-Lymphoma Institute of Hematology & Blood Diseases Hospital, China 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06930105What this trial is testingImpact of Low-intensity Chemotherapy Combined With Short-course Blinatumomab on Allo-HSCT in Adults With Ph- B-ALLWho this might be right forAcute Lymphoid Leukemia (ALL) Xianmin Song, MD 45
Early research (Phase 1)Study completedNCT01132573What this trial is testingEntinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic LeukemiaWho this might be right forAcute Leukemias of Ambiguous LineagePhiladelphia Chromosome Negative Adult Precursor Acute Lymphoblastic LeukemiaRecurrent Adult Acute Lymphoblastic Leukemia+1 more National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Study completedNCT03367299What this trial is testingSequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoid LeukemiaPhiladelphia Chromosome-Negative B-Cell Precursor Gruppo Italiano Malattie EMatologiche dell'Adulto 149
Testing effectiveness (Phase 2)UnknownNCT02744768What this trial is testingD-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 60
Testing effectiveness (Phase 2)Study completedNCT00391989What this trial is testingTreatment of Adult Ph+ LAL With BMS-354825Who this might be right forLymphoblastic Leukemia, Acute Gruppo Italiano Malattie EMatologiche dell'Adulto 53
Not applicableLooking for participantsNCT06237192What this trial is testingMRD-associated Non-intensive But Non-interruptive Treatment of Ph-negative Acute Lymphoblastic Leukemia Adult PatientsWho this might be right forPrecursor Cell Lymphoblastic Leukemia-Lymphoma National Research Center for Hematology, Russia 200
Testing effectiveness (Phase 2)Looking for participantsNCT06738368What this trial is testingEtoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic LeukemiaWho this might be right forB Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeT Acute Lymphoblastic Leukemia University of Washington 30
Testing effectiveness (Phase 2)Looking for participantsNCT07387926What this trial is testingSafety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Lymphoblastic LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-PositivePhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Ended earlyNCT01028716What this trial is testingDonor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAcute Biphenotypic LeukemiaAcute Erythroid Leukemia in RemissionAcute Leukemia in Remission+27 more Fred Hutchinson Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT01427881What this trial is testingCyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more Fred Hutchinson Cancer Center 43
Early research (Phase 1)Study completedNCT00114257What this trial is testingDecitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative DisordersWho this might be right forChronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more National Cancer Institute (NCI) 36
Large-scale testing (Phase 3)Active Not RecruitingNCT04994717What this trial is testingStudy Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic LeukemiaWho this might be right forNewly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL) Amgen 303
Testing effectiveness (Phase 2)Looking for participantsNCT06250959What this trial is testingRDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL.Who this might be right forALL, AdultPhiladelphia-Negative ALL Chen Suning 124
Testing effectiveness (Phase 2)Looking for participantsNCT06918431What this trial is testingAsparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaWho this might be right forB Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeLymphoblastic Lymphoma City of Hope Medical Center 53
Testing effectiveness (Phase 2)Study completedNCT00495079What this trial is testingSafety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia (ALL) Spectrum Pharmaceuticals, Inc 65
Large-scale testing (Phase 3)Not Yet RecruitingNCT07223190What this trial is testingA Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precursor Acute Lymphoblastic LeukaemiaWho this might be right forPhiladelphia Chromosome Negative B-cell Precursor Acute Lymphoblastic Leukemia Amgen 560
Testing effectiveness (Phase 2)UnknownNCT04688983What this trial is testingStudy in Adult Ph-positive ALLWho this might be right forAcute Lymphoblastic Leukemia, Adult Cardiff University 180